Safe technique of supracalviaclar block; using nalpuphine as an adjuvant for low concentration, low volume of levobupivacine in single shot ultrasound

Safe technique of supracalviaclar block; using nalpuphine as an adjuvant for low concentration, low volume of levobupivacine in single shot ultrasound-guided supraclavicular block. (RCT)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201705002264264

Enrollment

135

Registered

2017-05-04

Start date

2016-04-03

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery post operative pain

Interventions

control group (group L)

group H

group N

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients coming for hand & forearm surgery age between 20-60 years old weight between 50 and 100 kg classified by the American Society of Anesthesiologist (ASA) physical status as class I, II & III.

Exclusion criteria

Exclusion criteria: patient¿s refusal history of allergic reactions to local anaesthetics coagulopathy anatomical deformities or infection at the block site neurological deficits on the operated extremity ASA risk classification of IV.

Design outcomes

Primary

Measure	Time frame
onset of sensory and motor block;duration of sensory and motror blocks;duration of first anlgisic dose	—

Secondary

Measure	Time frame
heart rate & mean blood pressure;nalbuphine complications i.e. nausea, vomiting, sedation & pruritis	—

Countries

Egypt

Contacts

Public ContactHeba;Bassant Omar;Abdel-Hamid

lecturer at anesthesia, surgical ICU & pain department, faculty of medicine;lecturer of anesthesia, surgical ICU & pain management department, faculty of medicine

Hebaomar2@yahoo.com;Bassantmohamed197@yahooo.com+2-01128102222;01224254012

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026